QUACPAC
QUACPAC offers everything necessary to do charges well. As the chemistry of molecular interactions is a matter of shape and electrostatics, accurate or at least consistent charge representation is critical in drug design. However, even the best charge models are of limited value if protonation states are wrong.
QUACPAC provides pKa and tautomer enumeration in order to get correct protonation states. It also offers multiple partial charge models (including MMFF94 [1], AM1-BCC [2], and AMBER [3]) that cover a range of speed and quality in order to allow appropriate charging for every end use.
Features
- Protonation state enumeration for pH 2-14
- Tautomer enumeration and canonicalization
- Gasteiger and MMFF94 [1] partial charges at about 1000 molecules per second
- HF/6-31G* quality charges with AM1-BCC [2] at 1 molecule per second for drug-sized molecules
- Set a single favorable ionization state for pH=7.4
QUACPAC's approach to tautomeric enumeration is to provide multiple tautomeric states rather than one "correct" tautomer. Subsequent downstream processes are then used to identify the appropriate tautomeric form.
For more detailed information on QUACPAC, check out the link below:
DocumentationReferences
- Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 Halgren, T. A. J. Comp. Chem, 1996 17, 490.
- Fast, efficient generation of high-quality atomic charges: AM1-BCC Model. II: Parameterization and validation Jaklian, A., Jack, D.B. and Bayly, C., J. Comp. Chem, 2002, 23, 1623-1641.
- Application of the multimolecule and multiconformational RESP methodology to biopolymers: Charge derivation for DNA, RNA, and proteins Cieplak, P., Cornell, W.D., Bayly, C. and Kollman, P.A., J. Comp. Chem, 1995, 16, 1357.
miniCUP San Francisco 2024
BAGIM Holiday Event
miniCUP Boston 2024
OpenEye Releases Additional Virtual Screening COVID-19 Data to Public
Accelerating Similarity and Substructure Searches
miniWebinar: Opening up the druggable universe one cryptic pocket at a time
CUP XXIV - Santa Fe March 4-6, 2025
Essentials of Computational Drug Discovery | Sep-Dec 2024
Easier is Better
Relative Binding Free Energy with Non-Equilibrium Switching in Orion
OpenEye deploys the Orion platform to find COVID-19 therapeutics
Conversations at CUP: Paul Hawkins & John D. Chodera
Conversations at CUP: Geoff Skillman & Charlotte Deane
CCDC’s GOLD Now Available on Orion®
Conversations at CUP: Anthony Nicholls & Christian Cortis
Orion Integrates Synple Chem to Generate Hits On-Demand